Giovanna Gallo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Endocrine functions of the heart: from bench to bedside	EUROPEAN HEART JOURNAL	2022
Updated Recommendations on Cardiovascular Prevention in 2022. An Executive Document of the Italian Society of Cardiovascular Prevention	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2022
Correction to .updated recommendations on cardiovascular prevention in 2022: an executive document of the italian society of cardiovascular prevention	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2022
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2021
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company	JOURNAL OF HUMAN HYPERTENSION	2021
Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy	BIOMOLECULES	2021
Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy	BIOMOLECULES	2021
A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2021
A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era	FRONTIERS IN PHYSIOLOGY	2021
Sacubitril/Valsartan as a therapeutic tool across the range of Heart Failure phenotypes and ejection fraction spectrum	FRONTIERS IN PHYSIOLOGY	2021
Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension. one shot for a double strike?	EUROPEAN HEART JOURNAL	2021
Are post-hoc analyses on subgroups sufficient to support new treatment algorithms of heart failure? The case of SGLT2 inhibitors associated with sacubitril/valsartan	CARDIOLOGY	2021
Novel ANP (Atrial Natriuretic Peptide) based therapy for hypertension: the promising role of a disease mechanism targeted approach	HYPERTENSION	2021
Targeting cyclic guanylate monophosphate in resistant hypertension and heart failure. Are sacubitril/valsartan and vericiguat synergistic and effective in both conditions?	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2021
Cardiopulmonary exercise testing: An increasingly important step in managing hypertrophic cardiomyopathy.	INTERNATIONAL JOURNAL OF CARDIOLOGY	2021
[Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]	GIORNALE ITALIANO DI CARDIOLOGIA	2021
A Plea for Smoking-Free Policies in COVID-19 Times: Cardiovascular Prevention as an Ally in Coronavirus Containment	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2021
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction	ESC HEART FAILURE	2020
Functional Role of Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral Regurgitation	JOURNAL OF CLINICAL MEDICINE	2020
Cardiovascular death risk in recovered mid-range ejection fraction heart failure. insights from cardiopulmonary exercise test	JOURNAL OF CARDIAC FAILURE	2020

Gruppi di ricerca

Ipertensione arteriosa e prevenzione cardiovascolare

Disregolazione neurormonale nelle malattie cardiovascolari

Disfunzione mitocondriale e stress ossidativo nelle malattie cardiovascolari